ALTIMMUNE INC (ALT) Stock Fundamental Analysis

NASDAQ:ALT • US02155H2004

4.38 USD
-0.11 (-2.45%)
Last: Feb 20, 2026, 12:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, ALT scores 3 out of 10 in our fundamental rating. ALT was compared to 521 industry peers in the Biotechnology industry. The financial health of ALT is average, but there are quite some concerns on its profitability. ALT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ALT had negative earnings in the past year.
  • ALT had a negative operating cash flow in the past year.
  • ALT had negative earnings in each of the past 5 years.
  • ALT had a negative operating cash flow in each of the past 5 years.
ALT Yearly Net Income VS EBIT VS OCF VS FCFALT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -38.41%, ALT perfoms like the industry average, outperforming 59.69% of the companies in the same industry.
  • ALT's Return On Equity of -45.21% is fine compared to the rest of the industry. ALT outperforms 68.52% of its industry peers.
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROIC N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ALT Yearly ROA, ROE, ROICALT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ALT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALT Yearly Profit, Operating, Gross MarginsALT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALT has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALT has more shares outstanding
  • There is no outstanding debt for ALT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALT Yearly Shares OutstandingALT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALT Yearly Total Debt VS Total AssetsALT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 5.02 indicates that ALT is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ALT (5.02) is better than 71.78% of its industry peers.
  • ALT has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALT (0.08) is worse than 60.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 5.02
ROIC/WACCN/A
WACC8.73%
ALT Yearly LT Debt VS Equity VS FCFALT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • ALT has a Current Ratio of 17.18. This indicates that ALT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 17.18, ALT belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
  • A Quick Ratio of 17.18 indicates that ALT has no problem at all paying its short term obligations.
  • ALT has a Quick ratio of 17.18. This is amongst the best in the industry. ALT outperforms 93.86% of its industry peers.
Industry RankSector Rank
Current Ratio 17.18
Quick Ratio 17.18
ALT Yearly Current Assets VS Current LiabilitesALT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ALT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.15%, which is quite impressive.
  • The Revenue for ALT has decreased by -61.54% in the past year. This is quite bad
  • ALT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -67.82% yearly.
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%

3.2 Future

  • ALT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.08% yearly.
  • ALT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 889.71% yearly.
EPS Next Y26.05%
EPS Next 2Y3.55%
EPS Next 3Y5.36%
EPS Next 5Y38.08%
Revenue Next Year112.6%
Revenue Next 2Y-6.41%
Revenue Next 3Y1778.25%
Revenue Next 5Y889.71%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALT Yearly Revenue VS EstimatesALT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 500M 1B 1.5B
ALT Yearly EPS VS EstimatesALT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALT. In the last year negative earnings were reported.
  • Also next year ALT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALT Price Earnings VS Forward Price EarningsALT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALT Per share dataALT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.55%
EPS Next 3Y5.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALTIMMUNE INC

NASDAQ:ALT (2/20/2026, 12:22:09 PM)

4.38

-0.11 (-2.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners40.5%
Inst Owner Change20.39%
Ins Owners0.63%
Ins Owner Change3.48%
Market Cap494.20M
Revenue(TTM)20.00K
Net Income(TTM)-83.92M
Analysts78.67
Price Target18.67 (326.26%)
Short Float %21.57%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.69%
Min EPS beat(2)17.24%
Max EPS beat(2)26.14%
EPS beat(4)4
Avg EPS beat(4)18.17%
Min EPS beat(4)0.21%
Max EPS beat(4)29.11%
EPS beat(8)7
Avg EPS beat(8)14.31%
EPS beat(12)11
Avg EPS beat(12)15.65%
EPS beat(16)15
Avg EPS beat(16)15.29%
Revenue beat(2)2
Avg Revenue beat(2)296.04%
Min Revenue beat(2)296.04%
Max Revenue beat(2)296.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.78%
PT rev (3m)-0.78%
EPS NQ rev (1m)-49.61%
EPS NQ rev (3m)75.23%
EPS NY rev (1m)0.03%
EPS NY rev (3m)11.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)88.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24709.77
P/FCF N/A
P/OCF N/A
P/B 2.66
P/tB 2.66
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-1.24
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0
BVpS1.64
TBVpS1.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.18
Quick Ratio 17.18
Altman-Z 5.02
F-Score3
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
EPS Next Y26.05%
EPS Next 2Y3.55%
EPS Next 3Y5.36%
EPS Next 5Y38.08%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%
Revenue Next Year112.6%
Revenue Next 2Y-6.41%
Revenue Next 3Y1778.25%
Revenue Next 5Y889.71%
EBIT growth 1Y9.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.22%
EBIT Next 3Y-13.84%
EBIT Next 5Y13.78%
FCF growth 1Y13.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.37%
OCF growth 3YN/A
OCF growth 5YN/A

ALTIMMUNE INC / ALT FAQ

What is the ChartMill fundamental rating of ALTIMMUNE INC (ALT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALT.


What is the valuation status for ALT stock?

ChartMill assigns a valuation rating of 0 / 10 to ALTIMMUNE INC (ALT). This can be considered as Overvalued.


Can you provide the profitability details for ALTIMMUNE INC?

ALTIMMUNE INC (ALT) has a profitability rating of 1 / 10.


How financially healthy is ALTIMMUNE INC?

The financial health rating of ALTIMMUNE INC (ALT) is 5 / 10.